P
23.85
-0.15 (-0.62%)
AIStockmoo Score
0.0
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Murchinson Ltd. | 31 Dec 2025 | 289,479 |
| Ikarian Capital, Llc | 31 Dec 2025 | 255,758 |
| J. Goldman & Co Lp | 31 Dec 2025 | 78,006 |
| Cantor Fitzgerald, L. P. | 31 Dec 2025 | 34,990 |
| Diadema Partners Lp | 31 Dec 2025 | 25,000 |
| Knott David M Jr | 31 Dec 2025 | 19,281 |
| Pale Fire Capital Se | 31 Dec 2025 | 8,100 |
| Persistent Asset Partners Ltd | 31 Dec 2025 | 6,007 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 15 Jan 2026 | Announcement | Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics |
| 13 Jan 2026 | Announcement | Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance |
| 05 Jan 2026 | Announcement | Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice |
| 23 Dec 2025 | Announcement | Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |